title: Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas.
abstract: The purpose of this study was to determine the angiogenic profile of human esophageal carcinomas. The expression of vascular endothelial growth factor (VEGF) was examined in 6 esophageal carcinoma cell lines and 119 human esophageal carcinoma tissues by Northern blot analysis and immunohistochemistry, respectively. Immunohistochemistry using antibodies against CD34 (endothelial cell specific) was carried out on archival specimens, and microvessels were quantitated by counting vessels in a x200 field in the most vascular area of the tumor. All of the cell lines constitutively expressed VEGF mRNA at various levels. A total of 71 of 119 (59.7%) tumors showed intense VEGF immunoreactivity in the cytoplasm of cancer cells. Vessel count was significantly higher in the VEGF-positive tumors than it was in the VEGF-negative tumors. VEGF expression correlated with the depth of tumor invasion, tumor stage, venous invasion, and lymphatic invasion. The survival rate of patients with high vessel density in the tumor was significantly worse than that of patients with low vessel density in the tumor. There was a tendency for poorer prognosis in the group with VEGF-positive tumors compared with that of the group with VEGF-negative tumors. Overall, these results suggest that VEGF is associated with tumor progression by stimulating angiogenesis in human esophageal carcinoma.
authors.affiliation: First Department of Internal Medicine, Hiroshima University School of Medicine, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Kitadai
authors.forename: K
authors.initials: K
authors.lastname: Haruma
authors.forename: T
authors.initials: T
authors.lastname: Tokutomi
authors.forename: S
authors.initials: S
authors.lastname: Tanaka
authors.forename: K
authors.initials: K
authors.lastname: Sumii
authors.forename: M
authors.initials: M
authors.lastname: Carvalho
authors.forename: M
authors.initials: M
authors.lastname: Kuwabara
authors.forename: K
authors.initials: K
authors.lastname: Yoshida
authors.forename: T
authors.initials: T
authors.lastname: Hirai
authors.forename: G
authors.initials: G
authors.lastname: Kajiyama
authors.forename: E
authors.initials: E
authors.lastname: Tahara
mesh_terms: D015152:Blotting, Northern; D002294:Carcinoma, Squamous Cell / Q000098:blood supply* / Q000378:metabolism*; D018450:Disease Progression; D016228:Endothelial Growth Factors / Q000096:biosynthesis*; D004938:Esophageal Neoplasms / Q000098:blood supply* / Q000378:metabolism*; D006801:Humans; D008222:Lymphokines / Q000096:biosynthesis*; D009389:Neovascularization, Pathologic / Q000378:metabolism*; D011379:Prognosis; D014407:Tumor Cells, Cultured; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
chemical_list: D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors